Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor

被引:0
|
作者
L-K Han
Y Kimura
M Kawashima
T Takaku
T Taniyama
T Hayashi
Y-N Zheng
H Okuda
机构
[1] School of Medicine,2nd Department of Medical Biochemistry
[2] Ehime University,undefined
[3] Central Research Laboratory,undefined
[4] Ehime University,undefined
[5] Koshiro Pharmaceutical Co. Ltd,undefined
[6] The Pharmaceutical Institute,undefined
[7] Dalian University,undefined
来源
关键词
teasaponin; pancreatic lipase; high-fat diet;
D O I
暂无
中图分类号
学科分类号
摘要
OBJECTIVE: Based on the inhibitory effects of teasaponin on pancreatic lipase activity in vitro, this study was performed to clarify whether teasaponin prevented obesity induced in mice by a high-fat diet for 11 weeks.
引用
收藏
页码:1459 / 1464
页数:5
相关论文
共 50 条
  • [41] Different dietary fibers unequally remodel gut microbiota and charge up anti-obesity effects
    Wen, Jia-Jia
    Li, Ming-Zhi
    Hu, Jie-Lun
    Wang, Jiang
    Wang, Zhi-Qiang
    Chen, Chun-Hua
    Yang, Jing-Rui
    Huang, Xiao-Jun
    Xie, Ming-Yong
    Nie, Shao-Ping
    FOOD HYDROCOLLOIDS, 2023, 140
  • [42] Anti-obesity therapies
    Melnikova, I
    Wages, D
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (05) : 369 - 370
  • [43] Anti-obesity potential of 4,4-dimethylsterols by inhibiting pancreatic lipase
    Zhang, Tao
    Wang, Xingguo
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 2022, 99 : 86 - 86
  • [44] Anti-obesity proteins
    Becker, Gerald W.
    Hale, John
    MacKellar, Warren
    Biotechnology Advances, 1997, 15 (3-4):
  • [45] Anti-obesity therapies
    Irena Melnikova
    David Wages
    Nature Reviews Drug Discovery, 2006, 5 : 369 - 370
  • [46] Anti-obesity drugs
    Rankin, Wayne
    Wittert, Gary
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (06) : 536 - 543
  • [47] Anti-obesity effects of angiotensin converting enzyme inhibitor are mediated by brown adipose tissue activation
    Zhai, Baiqiang
    Zhou, Huiqiao
    Chen, Li
    Qiu, Wanru
    Yang, Mingsheng
    Luo, Yunbo
    Liu, Xiaomeng
    SCIENCE BULLETIN, 2018, 63 (05) : 275 - 277
  • [48] Anti-obesity drugs
    Kushner, Robert F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (08) : 1339 - 1350
  • [49] Anti-obesity drugs: to be or not to be?
    Dvorak, R. V.
    Sharma, A. M.
    Astrup, A.
    OBESITY REVIEWS, 2010, 11 (12) : 833 - 834
  • [50] A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy
    Tan, Yong Chia
    Gan, Chee-Yuen
    Shafie, Muhammad Hakimin
    Yap, Pei Gee
    Rodhi, Ainolsyakira Mohd
    Ahmad, Ashfaq
    Murugaiyah, Vikneswaran
    Abdulla, Mohammed H.
    Johns, Edward James
    ELECTRONIC JOURNAL OF GENERAL MEDICINE, 2023, 20 (03):